Cargando…

Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis

BACKGROUND: Huai Hua San (HHS), a famous Traditional Chinese Medicine (TCM) formula, has been widely applied in treating ulcerative colitis (UC). However, the interaction of bioactives from HHS with the targets involved in UC has not been elucidated yet. AIM: A network pharmacology-based approach co...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jiaqin, Liu, Jian, Tong, Xiaoliang, Peng, Weijun, Wei, Shanshan, Sun, Taoli, Wang, Yikun, Zhang, Bikui, Li, Wenqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326529/
https://www.ncbi.nlm.nih.gov/pubmed/34349502
http://dx.doi.org/10.2147/DDDT.S319786
_version_ 1783731848543731712
author Liu, Jiaqin
Liu, Jian
Tong, Xiaoliang
Peng, Weijun
Wei, Shanshan
Sun, Taoli
Wang, Yikun
Zhang, Bikui
Li, Wenqun
author_facet Liu, Jiaqin
Liu, Jian
Tong, Xiaoliang
Peng, Weijun
Wei, Shanshan
Sun, Taoli
Wang, Yikun
Zhang, Bikui
Li, Wenqun
author_sort Liu, Jiaqin
collection PubMed
description BACKGROUND: Huai Hua San (HHS), a famous Traditional Chinese Medicine (TCM) formula, has been widely applied in treating ulcerative colitis (UC). However, the interaction of bioactives from HHS with the targets involved in UC has not been elucidated yet. AIM: A network pharmacology-based approach combined with molecular docking and in vitro validation was performed to determine the bioactives, key targets, and potential pharmacological mechanism of HHS against UC. MATERIALS AND METHODS: Bioactives and potential targets of HHS, as well as UC-related targets, were retrieved from public databases. Crucial bioactive ingredients, potential targets, and signaling pathways were acquired through bioinformatics analysis, including protein–protein interaction (PPI), as well as the Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. Subsequently, molecular docking was carried out to predict the combination of active compounds with core targets. Lastly, in vitro experiments were conducted to further verify the findings. RESULTS: A total of 28 bioactive ingredients of HHS and 421 HHS-UC-related targets were screened. Bioinformatics analysis revealed that quercetin, luteolin, and nobiletin may be potential candidate agents. JUN, TP53, and ESR1 could become potential therapeutic targets. PI3K-AKT signaling pathway might play an important role in HHS against UC. Moreover, molecular docking suggested that quercetin, luteolin, and nobiletin combined well with JUN, TP53, and ESR1, respectively. Cell experiments showed that the most important ingredient of HHS, quercetin, could inhibit the levels of inflammatory factors and phosphorylated c-Jun, as well as PI3K-Akt signaling pathway in LPS-induced RAW264.7 cells, which further confirmed the prediction by network pharmacology strategy and molecular docking. CONCLUSION: Our results comprehensively illustrated the bioactives, potential targets, and molecular mechanism of HHS against UC. It also provided a promising strategy to uncover the scientific basis and therapeutic mechanism of TCM formulae in treating diseases.
format Online
Article
Text
id pubmed-8326529
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-83265292021-08-03 Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis Liu, Jiaqin Liu, Jian Tong, Xiaoliang Peng, Weijun Wei, Shanshan Sun, Taoli Wang, Yikun Zhang, Bikui Li, Wenqun Drug Des Devel Ther Original Research BACKGROUND: Huai Hua San (HHS), a famous Traditional Chinese Medicine (TCM) formula, has been widely applied in treating ulcerative colitis (UC). However, the interaction of bioactives from HHS with the targets involved in UC has not been elucidated yet. AIM: A network pharmacology-based approach combined with molecular docking and in vitro validation was performed to determine the bioactives, key targets, and potential pharmacological mechanism of HHS against UC. MATERIALS AND METHODS: Bioactives and potential targets of HHS, as well as UC-related targets, were retrieved from public databases. Crucial bioactive ingredients, potential targets, and signaling pathways were acquired through bioinformatics analysis, including protein–protein interaction (PPI), as well as the Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. Subsequently, molecular docking was carried out to predict the combination of active compounds with core targets. Lastly, in vitro experiments were conducted to further verify the findings. RESULTS: A total of 28 bioactive ingredients of HHS and 421 HHS-UC-related targets were screened. Bioinformatics analysis revealed that quercetin, luteolin, and nobiletin may be potential candidate agents. JUN, TP53, and ESR1 could become potential therapeutic targets. PI3K-AKT signaling pathway might play an important role in HHS against UC. Moreover, molecular docking suggested that quercetin, luteolin, and nobiletin combined well with JUN, TP53, and ESR1, respectively. Cell experiments showed that the most important ingredient of HHS, quercetin, could inhibit the levels of inflammatory factors and phosphorylated c-Jun, as well as PI3K-Akt signaling pathway in LPS-induced RAW264.7 cells, which further confirmed the prediction by network pharmacology strategy and molecular docking. CONCLUSION: Our results comprehensively illustrated the bioactives, potential targets, and molecular mechanism of HHS against UC. It also provided a promising strategy to uncover the scientific basis and therapeutic mechanism of TCM formulae in treating diseases. Dove 2021-07-28 /pmc/articles/PMC8326529/ /pubmed/34349502 http://dx.doi.org/10.2147/DDDT.S319786 Text en © 2021 Liu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Liu, Jiaqin
Liu, Jian
Tong, Xiaoliang
Peng, Weijun
Wei, Shanshan
Sun, Taoli
Wang, Yikun
Zhang, Bikui
Li, Wenqun
Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis
title Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis
title_full Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis
title_fullStr Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis
title_full_unstemmed Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis
title_short Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis
title_sort network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of huai hua san against ulcerative colitis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326529/
https://www.ncbi.nlm.nih.gov/pubmed/34349502
http://dx.doi.org/10.2147/DDDT.S319786
work_keys_str_mv AT liujiaqin networkpharmacologypredictionandmoleculardockingbasedstrategytodiscoverthepotentialpharmacologicalmechanismofhuaihuasanagainstulcerativecolitis
AT liujian networkpharmacologypredictionandmoleculardockingbasedstrategytodiscoverthepotentialpharmacologicalmechanismofhuaihuasanagainstulcerativecolitis
AT tongxiaoliang networkpharmacologypredictionandmoleculardockingbasedstrategytodiscoverthepotentialpharmacologicalmechanismofhuaihuasanagainstulcerativecolitis
AT pengweijun networkpharmacologypredictionandmoleculardockingbasedstrategytodiscoverthepotentialpharmacologicalmechanismofhuaihuasanagainstulcerativecolitis
AT weishanshan networkpharmacologypredictionandmoleculardockingbasedstrategytodiscoverthepotentialpharmacologicalmechanismofhuaihuasanagainstulcerativecolitis
AT suntaoli networkpharmacologypredictionandmoleculardockingbasedstrategytodiscoverthepotentialpharmacologicalmechanismofhuaihuasanagainstulcerativecolitis
AT wangyikun networkpharmacologypredictionandmoleculardockingbasedstrategytodiscoverthepotentialpharmacologicalmechanismofhuaihuasanagainstulcerativecolitis
AT zhangbikui networkpharmacologypredictionandmoleculardockingbasedstrategytodiscoverthepotentialpharmacologicalmechanismofhuaihuasanagainstulcerativecolitis
AT liwenqun networkpharmacologypredictionandmoleculardockingbasedstrategytodiscoverthepotentialpharmacologicalmechanismofhuaihuasanagainstulcerativecolitis